-
Pfizer announces closure of St. Louis Sites
Pfizer annouces closure of its Saint Louis research facilities. A number of scientist became available to the labor market over the next following months. -
Saint Louis University Announcement
Saint Louis University announces that it will establish a new center to combat neglected and orphan diseases in an effort to help preserve scientific talent in the Saint Louis area. -
Labs Open
The Center for World Health and Medicine opens its doors at the Doisy Research Center at Saint Louis University. Its initial staff includes 11 pharmaceutical scientist. -
Combating Childhood Diarrhea
CWHM initiates its first in vivo studies to combat childhood diarrhea. Initial compounds tested are Racecadotril (left) and Loperamide (right). -
First biochemical assays initiated
First biochemical assays initiated at the CWHM. The assay looks at NEP enzyme activity using a synthetic substrate and is a key assay in the fight against Childhood Diarrhea -
First Compound Synthesized at CWHM
Fluorescence polarization probe for HSP90 -
First HSP90 Binding assay
First HSP90 Binding assay is executed at CWHM -
1st Drug Candidate
First potential drug candidate is synthesized at CWHM -
GIBH
CWHM partners with China's Guangzhou Institutes of Biomedicine and Health to combat malaria -
Drug synthesized with GIBH
First drug sythesized in effort to combat malaria in collaboration with GIBH in China -
First erythrocyte assay in collaboration with GIBH
First erythrocyte assay in collaboration with GIBH, testing the first compounds synthesized for this project. -
CWHM and iOWH join forces.
CWHM and Institute for One World Health join forces to combat childhood diarrhea, the second leading cause of death in children under 5 in developing countries.
